Viewing Study NCT02280434


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-27 @ 12:48 AM
Study NCT ID: NCT02280434
Status: COMPLETED
Last Update Posted: 2016-11-03
First Post: 2014-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study Accessing the Safety and Tolerability of CBP-307
Sponsor: Connect Biopharm LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module